Abeona Therapeutics Inc (NASDAQ: ABEO) on Monday, soared 6.46% from the previous trading day, before settling in for the closing price of $5.11. Within the past 52 weeks, ABEO’s price has moved between $3.93 and $7.54.
During the last 5-year period, the sales growth of Healthcare Sector giant was 47.21%. The company achieved an average annual earnings per share of 174.84%. With a float of $49.46 million, this company’s outstanding shares have now reached $52.40 million.
Abeona Therapeutics Inc (ABEO) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Abeona Therapeutics Inc is 8.73%, while institutional ownership is 62.41%. The most recent insider transaction that took place on Nov 13 ’25, was worth 71,168. In this transaction Director of this company sold 15,000 shares at a rate of $4.74, taking the stock ownership to the 62,252 shares. Before that another transaction happened on Nov 13 ’25, when Company’s Director proposed sale 15,000 for $4.74, making the entire transaction worth $71,168.
Abeona Therapeutics Inc (ABEO) Recent Fiscal highlights
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.32 earnings per share (EPS) for the period topping the consensus outlook (set at -0.34) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.1 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 174.84% per share during the next fiscal year.
Abeona Therapeutics Inc (NASDAQ: ABEO) Trading Performance Indicators
Abeona Therapeutics Inc (ABEO) is currently performing well based on its current performance indicators. A quick ratio of 9.53 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 737.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.17, a number that is poised to hit -0.33 in the next quarter and is forecasted to reach -0.13 in one year’s time.
Technical Analysis of Abeona Therapeutics Inc (ABEO)
Looking closely at Abeona Therapeutics Inc (NASDAQ: ABEO), its last 5-days average volume was 1.12 million, which is a drop from its year-to-date volume of 1.19 million. As of the previous 9 days, the stock’s Stochastic %D was 44.31%.
During the past 100 days, Abeona Therapeutics Inc’s (ABEO) raw stochastic average was set at 40.68%, which indicates a significant decrease from 84.65% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.27 in the past 14 days, which was higher than the 0.27 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.94, while its 200-day Moving Average is $5.66. However, in the short run, Abeona Therapeutics Inc’s stock first resistance to watch stands at $5.64. Second resistance stands at $5.84. The third major resistance level sits at $6.13. If the price goes on to break the first support level at $5.15, it is likely to go to the next support level at $4.86. Now, if the price goes above the second support level, the third support stands at $4.66.
Abeona Therapeutics Inc (NASDAQ: ABEO) Key Stats
Market capitalization of the company is 294.80 million based on 54,191K outstanding shares. Right now, sales total 0 K and income totals -63,730 K. The company made 400 K in profit during its latest quarter, and 108,830 K in sales during its previous quarter.
